A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for widely used ...
1d
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the ...
WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, ...
Results from Medicare’s first year of negotiation with other price benchmarks shed light on the competitive dynamics and ...
The Inflation Reduction Act raids an estimated $260 billion in reduced Medicare drug spending to pay for unrelated spending.
President Joe Biden’s Inflation Reduction Act allows Medicare to negotiate costly drug prices with pharmaceutical companies.
Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of ...
The Centers for Medicare & Medicaid Services (CMS) has said it will announce the next 15 drugs in scope for the second round ...
When CMS begins negotiations for physician-administered drugs under the Inflation Reduction Act, providers, including those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback